September 22, 2010
GREENWICH, CT and ANN ARBOR, MI – Biotronic NeuroNetwork (“Biotronic”), a Great Point Partners I, L.P. (“GPP”) portfolio company and the leading intraoperative neurophysiological monitoring (“IONM”) company in the United States, recently received recognition in Modern Healthcare’s September 20th issue as one of the Top 20 Outsourcing Firms in the United States. Please contact Great Point Partners for a PDF copy of the article.
Dr. Gene Balzer, Chief Executive Officer of Biotronic, said, “The biggest trend for us is that the hospitals we work with are looking at outsourcing as a standardized risk-management tool to give better care to patients.” When asked further about why Biotronic in particular has found such success with hospitals, Dr. Balzer stated, “The hospitals want a sole-source vendor that can provide quality assessment reports and that can follow set protocols; Biotronic consistently matches their needs.”
Adam Dolder, MD, Managing Director of Great Point Partners and Chairman of Biotronic stated, “Biotronic’s growth is directly reflective of the trends and pressures facing hospitals today as hospitals look to ease overall management complexity, appropriately manage their cost infrastructure while also providing the best clinical care possible. Biotronic enables its customers to do that with respect to IONM services.” Jeffrey Jay M.D. co-founder of Great Point Partners and a member of Biotronic’s Board of Directors added, “We are pleased with Biotronic’s rapid growth and leading market position and congratulate all the Biotronic employees with the recognition the Company has received.”
Founded in 1978, Biotronic NeuroNetwork is headquartered in Ann Arbor, Michigan and currently employs over 225 administrative, support and clinical staff, including over 175 technicians throughout 17 states. Biotronic is the largest independent provider of intraoperative neurophysiological monitoring in the world, serving over 450 hospitals and 1,200 surgeons annually. www.biotronic.com.
About Great Point Partners, LLC
GPP, based in Greenwich, Connecticut, is a leading health care investment firm with approximately $400 million of equity capital under management. The firm manages capital in public and private equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 health care companies. Both the private and public funds invest across all sectors of the health care industry including biotechnology and life sciences, consumer health, generic drugs, health care services, information technology, insurance, medical devices, specialty pharmaceuticals, and workers compensation. The firm pursues a proactive and proprietary approach to sourcing investments. Reach Great Point at 203-971-3300 or at www.gppfunds.com.
This document is intended solely to provide information regarding Great Point Partners’ potential financing capabilities for prospective portfolio companies.